Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Burton

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Health Technology Assessment (Winchester, England)|October 4, 2024
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCTCatherine M Sackley, Caroline Rick, Marian C Brady, et al.
BMC Health Services Research|July 30, 2025
Delivering a national de-adoption programme: a documentary analysis of local commissioning policy compliance with England's Evidence-based Interventions programme (EBI)Carmel Conefrey, Nicola Farrar, Maeve Coyle, et al.
BMJ (Clinical Research Ed.)|July 10, 2024
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trialCatherine M Sackley, Caroline Rick, Marian C Brady, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Effectiveness of non-pharmacological interventions for fatigue in adults with long-term conditions: a synopsis of the EIFFEL mixed-methods evidence synthesisJoanna Leaviss, Andrew Booth, David Coyle, et al.
BMJ Medicine|March 19, 2026
Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysisJoanna Leaviss, Jessica E Forsyth, Andrew Booth, et al.
Lancet (London, England)|June 15, 2024
Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Journal of Clinical Microbiology|August 26, 2020
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and FixativesStephen R Welch, Katherine A Davies, Hubert Buczkowski, et al.
Health and Social Care Delivery Research|April 5, 2025
Multiple Symptoms Study 3 - An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled TrialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Scientific Reports|December 4, 2021
Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2Katherine Davies, Ulrike Arnold, Hubert Buczkowski, et al.
Implementation Science Communications|February 12, 2026
Exploring spillover effects following surgical de-implementation: An observational evaluation of primary care, referrals, and time to surgical intervention following reductions in the use of tonsillectomy and Dupuytren's contractureJoel Glynn, Timothy Jones, Sam Creavin, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Health Technology Assessment (Winchester, England)|October 4, 2024
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCTCatherine M Sackley, Caroline Rick, Marian C Brady, et al.
BMC Health Services Research|July 30, 2025
Delivering a national de-adoption programme: a documentary analysis of local commissioning policy compliance with England's Evidence-based Interventions programme (EBI)Carmel Conefrey, Nicola Farrar, Maeve Coyle, et al.
BMJ (Clinical Research Ed.)|July 10, 2024
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trialCatherine M Sackley, Caroline Rick, Marian C Brady, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Effectiveness of non-pharmacological interventions for fatigue in adults with long-term conditions: a synopsis of the EIFFEL mixed-methods evidence synthesisJoanna Leaviss, Andrew Booth, David Coyle, et al.
BMJ Medicine|March 19, 2026
Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysisJoanna Leaviss, Jessica E Forsyth, Andrew Booth, et al.
Lancet (London, England)|June 15, 2024
Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Journal of Clinical Microbiology|August 26, 2020
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and FixativesStephen R Welch, Katherine A Davies, Hubert Buczkowski, et al.
Health and Social Care Delivery Research|April 5, 2025
Multiple Symptoms Study 3 - An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled TrialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Scientific Reports|December 4, 2021
Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2Katherine Davies, Ulrike Arnold, Hubert Buczkowski, et al.
Implementation Science Communications|February 12, 2026
Exploring spillover effects following surgical de-implementation: An observational evaluation of primary care, referrals, and time to surgical intervention following reductions in the use of tonsillectomy and Dupuytren's contractureJoel Glynn, Timothy Jones, Sam Creavin, et al.
Pageof 13